Esertia

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

89 API Suppliers, 33 USDMF, 17 CEP/COS, 10 JDMF, 17 EU WC, 31 KDMF, 17 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

INTERMEDIATES

25 Intermediate Suppliers

25 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

909 FDF Dossiers, 84 FDA Orange Book, 567 Europe, 55 Canada, 78 Australia, 41 South Africa, 84 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE, SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 18 SPI Pharma, 2 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 21 BASF, 1 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 1 Gloria Interchem, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

69 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 31 Direct Compression, 31 Thickeners and Stabilizers, 28 Solubilizers, 25 Granulation, 24 Controlled & Modified Release, 24 Parenteral, 23 Film Formers & Plasticizers, 23 Disintegrants & Superdisintegrants, 20 Taste Masking, 19 Topical, 19 Chewable & Orodispersible Aids, 13 Lubricants & Glidants, 13 Co-Processed Excipients, 8 Emulsifying Agents, 8 Rheology Modifiers, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 73 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

16 APIs, 2 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

4 US Exclusivities, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 4 USP, 5 Others

$ Xls

Filters

FILTER :

filter Product Reset all filters

6 All

01 6Cipralex/Lexapro

01 Brand Name : Cipralex/Lexapro

Escitalopram

ESF Europe

Not Confirmed

02 Brand Name : Cipralex/Lexapro

Escitalopram

ESF Europe

Not Confirmed

03 Brand Name : Cipralex/Lexapro

Escitalopram

ESF Europe

Not Confirmed

04 Brand Name : Cipralex/Lexapro

Escitalopram

ESF Europe

Not Confirmed

05 Brand Name : Cipralex/Lexapro

Escitalopram

ESF Europe

Not Confirmed

06 Brand Name : Cipralex/Lexapro

Escitalopram

ESF Europe

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Esertia

Esertia

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

89 API Suppliers

33 USDMF

17 CEP/COS

10 JDMF

17 EU WC

31 KDMF

17 NDC API

42 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

40 Drugs in Development

INTERMEDIATES

25 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

909 FDF Dossiers

84 FDA Orange Book

567 Europe

55 Canada

78 Australia

41 South Africa

84 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 5MG BASE

SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Rochem International Inc

18 SPI Pharma

2 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

1 ACG Worldwide

9 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

21 BASF

1 CD Formulation

2 Clariant

10 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

1 Gloria Interchem

4 Ideal Cures

4 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

27 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

SOLUTION;ORAL - EQ 5MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons